It reports injection-site bruising in roughly 5 to 15 percent of patients in semaglutide studies, with similar rates for tirzepatide, and says most cases are mild and resolve within seven to 14 days without intervention
Company Highlights Proprietary DehydraTECH platform improves oral bioavailability and tolerability of active pharmaceutical ingredients (APIs), including GLP-1 drugs 65 patents granted globally across multiple sectors, with more awaiting Positive human and preclinical study results demonstrating improved absorption and reduced side effects in GLP-1 drug formulations Positioned to capitalize on rapid growth in oral GLP-1 treatments following recent FDA approvals, including Novo Nordisks Wegovy pill and Eli Lillys Foundayo Key Project DehydraTECH is Lexarias core technology, a patented formulation and processing platform that enhances oral drug delivery
Abnormal TSH levels suggest a thyroid disorder may be an underlying factor
Dietary Strategies to Feel Warmer and Energized Proteins Role in Nutrition and Muscle Building: Protein is a powerhouse nutrient, essential for muscle maintenance and growth, which in turn supports a healthy metabolism
What if I experience nausea on semaglutide
This delay has two theoretical consequences for co-administered oral drugs
